| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$198,559,401 |
|
|
|
Indirect Value
|
$175,231,488 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$373,790,889 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-20 |
4 |
S |
$3.14 |
$13,188 |
I/I |
(4,200) |
800,191 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-19 |
4 |
S |
$3.22 |
$13,714 |
I/I |
(4,259) |
804,391 |
0 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-05-20 |
4 |
B |
$11.04 |
$47,141 |
I/I |
4,270 |
12,071,158 |
2.25 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-12-12 |
4 |
S |
$1.80 |
$7,726 |
I/I |
(4,292) |
671,610 |
0 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-02 |
4 |
B |
$9.48 |
$40,764 |
D/D |
4,300 |
2,890,890 |
2.37 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-18 |
4 |
B |
$1.96 |
$8,913 |
I/I |
4,548 |
756,479 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-22 |
4 |
S |
$2.68 |
$12,231 |
I/I |
(4,571) |
508,802 |
0 |
% |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2011-05-03 |
4 |
B |
$13.01 |
$59,746 |
D/D |
4,591 |
3,146,879 |
2.39 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-24 |
4 |
S |
$3.06 |
$14,153 |
I/I |
(4,625) |
775,228 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-06 |
4 |
S |
$2.96 |
$14,507 |
I/I |
(4,901) |
856,115 |
0 |
% |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2010-06-14 |
4 |
B |
$11.25 |
$56,264 |
I/I |
5,000 |
651,126 |
2.1 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-11-07 |
5 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
1,434,028 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-01-02 |
4 |
B |
$18.43 |
$92,150 |
I/I |
5,000 |
10,731,589 |
2.25 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-02 |
4 |
B |
$1.95 |
$9,749 |
I/I |
5,000 |
603,254 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-23 |
4 |
B |
$2.03 |
$10,130 |
I/I |
5,000 |
772,297 |
1.5 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-08-13 |
4 |
A |
$18.08 |
$90,400 |
I/I |
5,000 |
2,112,023 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-08-14 |
4 |
A |
$18.20 |
$91,000 |
I/I |
5,000 |
2,117,023 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-08-16 |
4 |
A |
$18.37 |
$91,850 |
I/I |
5,000 |
2,132,023 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-08-19 |
4 |
A |
$18.29 |
$91,450 |
I/I |
5,000 |
2,137,023 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-11-12 |
4 |
A |
$15.32 |
$76,600 |
I/I |
5,000 |
2,162,023 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-11-13 |
4 |
A |
$16.04 |
$80,200 |
I/I |
5,000 |
1,267,023 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-11-14 |
4 |
A |
$15.75 |
$78,750 |
I/I |
5,000 |
2,167,023 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-12-06 |
4 |
A |
$15.94 |
$79,700 |
I/I |
5,000 |
2,172,023 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-12-09 |
4 |
A |
$15.72 |
$78,600 |
I/I |
5,000 |
2,177,023 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-04-24 |
4 |
B |
$10.00 |
$50,010 |
I/I |
5,001 |
14,685,245 |
2.25 |
% |
|
634 Records found
|
|
Page 6 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
